Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms
about
Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaPolyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteriaManagement of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic SocietyClinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteriaIn vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobialsSynergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosisSynergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophagesMolecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum.The new macrolides. Azithromycin and clarithromycin.Recurrent catheter-related infection caused by a single clone of Mycobacterium chelonae with two colonial morphotypes.Non-tuberculous mycobacterial tenosynovitis: a review.Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsActivities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.Mycobacterium fortuitum and Polymicrobial Peritoneal Dialysis-Related Peritonitis: A Case Report and Review of the Literature.Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitumClinical and laboratory features of Mycobacterium mageritense.Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.Activities of linezolid against rapidly growing mycobacteria.Azithromycin in DuraSite for the treatment of blepharitisMultidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient.High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.Chronic breast abscess due to Mycobacterium fortuitum: a case report.Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.Quantitative lipid composition of cell envelopes of Corynebacterium glutamicum elucidated through reverse micelle extractionEpidemiology of infection by nontuberculous mycobacteriaNontuberculous mycobacterial pulmonary infection in patients with cystic fibrosis: diagnosis and treatment.Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria IsolatesFighting tuberculosis: an old disease with new challenges.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.Disseminated Mycobacterium abscessus Infection Following Septic Arthritis: A Case Report and Review of the Literature.Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom.Evaluation of Etest for susceptibility testing of rapidly growing mycobacteriaMycobacterium chelonei breast abscess associated with nipple piercing.In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea.A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.
P2860
Q22241907-F99374A9-1264-42AA-9B10-0B4B09E0BA22Q24535187-2D07C804-A132-4045-B8D6-9FCFC47E4B95Q24535651-BC3B1501-507D-4342-8891-43D06838BB9AQ24679338-2A21A3AE-3B00-4B67-911B-150CE1918D7FQ28278933-7E676B27-FCF9-4F64-8314-F4176F4D5DE6Q28343826-92E284D7-21D6-461E-BD95-DF57D65BFFF7Q28367457-7D82F2AE-D432-4F7C-AD1D-D6C3B334D68EQ28379126-5B0E955D-635D-4B29-B22A-30C6AC9C7377Q33209766-75A0220E-5E49-4A93-B429-36FE2D2BF78CQ33607251-DE019AB6-A207-4115-838B-730D6B446C55Q33667274-2AC71549-F433-42FB-B886-ADEA21824B44Q33730779-9972DA0A-D818-40C9-94C7-7AD0D8EBD1B1Q33746042-F34467A0-B0CA-426C-ABA5-F9BA90D3A6F7Q33754030-78E9D040-F503-4AF2-A373-BC48773A7490Q33852872-F23D04AA-7AB0-43F7-9199-E05012152F59Q33960674-9DF5B51C-DAE9-46B3-A5EC-AFA1998C0503Q33965384-5ED88859-6547-4182-B75D-F737AF660123Q33965927-7B6C374E-2579-4450-9524-FBEC7B192E9AQ33971419-DD8DCEF4-742C-4E7F-AA08-9F67FC195664Q33981613-EEF1BFF7-97E4-4E52-86AA-A7F11B6A42C3Q34043273-E3EE2E98-BE03-4AE8-BD5C-81245247CDCBQ34058548-B9736F4E-AA4F-4490-B08E-17208165E7CCQ34530430-B700EEB2-DDAB-4315-9645-3D199E1643B2Q35014132-DE0F2E55-A909-43E4-B1E2-B3ABAE5A5DEEQ35056634-A4DA01C6-FC38-4100-820E-2ADDC2C52485Q35123617-41CEF870-9E71-4C2D-8591-F02723E127F0Q35216935-6CDBA940-7D1C-4B5A-A5E6-DA2CAD5E132CQ35370226-ADFC5911-4E23-4E77-B9B8-87A06390BF1EQ35627888-3E248BD4-7115-4393-853C-DDE855DDBF4EQ35749256-97EFCD5F-5B7C-4DBA-9F3F-87D41FE0A802Q35897225-C29DF236-16A1-40C0-903E-67FB1D8E6230Q36156072-0E532F87-DA14-4F52-AFB3-7EBFA271B63EQ36174064-A185C897-C3B2-4C44-B329-FA45ECE03049Q36193880-BA326DC1-FED6-4FA0-B404-F5AEE44ADF84Q36506301-6BB264C3-A7ED-48CA-BD69-92048A90606AQ36523174-14A5516E-68F1-4DB4-B55F-17320DD11B7AQ36624859-C5AF7588-E463-46C6-8E85-76DD50286740Q36854356-F95F6E4E-6A44-412D-97AD-4062025BA0F9Q37144788-F7C852BD-AE2F-4B33-8206-77DC1F0913FFQ37146435-250FAC0B-9F25-4AB0-99F3-885AFBD7D815
P2860
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Activities of four macrolides, ...... and M. chelonae-like organisms
@ast
Activities of four macrolides, ...... and M. chelonae-like organisms
@en
type
label
Activities of four macrolides, ...... and M. chelonae-like organisms
@ast
Activities of four macrolides, ...... and M. chelonae-like organisms
@en
prefLabel
Activities of four macrolides, ...... and M. chelonae-like organisms
@ast
Activities of four macrolides, ...... and M. chelonae-like organisms
@en
P2093
P2860
P356
P1476
Activities of four macrolides, ...... and M. chelonae-like organisms
@en
P2093
De Rosas V
Wallace RJ 3rd
Wallace RJ Jr
P2860
P304
P356
10.1128/AAC.36.1.180
P407
P577
1992-01-01T00:00:00Z